← Back to guidelines
Cardiology48 papers

Whipple's disease

Last edited: 4/15/2026

Overview

Whipple's disease is a rare, chronic infectious disorder caused by the bacterium Tropheryma whipplei, primarily affecting the gastrointestinal tract but potentially involving multiple organ systems including musculoskeletal and respiratory systems 123.

Diagnosis

  • Clinical Findings: Peripheral arthralgia, arthritis, inflammatory back pain, and gastrointestinal symptoms are common 1.
  • Diagnostic Tests: Polymerase Chain Reaction (PCR) testing of saliva and stool is frequently positive and recommended for diagnosis 1.
  • Response Criteria: Diagnosis supported by dramatic clinical improvement, including normalization of inflammatory markers like C-reactive protein, following antibiotic therapy 1.
  • Unique Manifestations: Acute fibrinous and organizing pneumonia can occur, indicating pulmonary involvement 2. Early manifestations may include IgA nephropathy and hypercalcemia 3.
  • Management

  • First-Line Treatment: Trimethoprim/sulfamethoxazole is effective for treating Whipple's disease 3.
  • Response Monitoring: Clinical improvement, including resolution of symptoms and normalization of inflammatory markers, should be monitored 13.
  • Special Populations

  • Comorbidities: IgA nephropathy and hypercalcemia can precede gastrointestinal symptoms and may require specific management alongside Whipple's disease treatment 3.
  • Key Recommendations

  • Perform PCR testing on saliva and stool in patients with suggestive rheumatological and gastrointestinal symptoms for early diagnosis (Evidence: Moderate 1).
  • Initiate trimethoprim/sulfamethoxazole for confirmed Whipple's disease, monitoring for clinical response and normalization of inflammatory markers (Evidence: Moderate 3).
  • Consider early manifestations such as IgA nephropathy and hypercalcemia as potential indicators of Whipple's disease, warranting further diagnostic evaluation (Evidence: Weak 3).
  • References

    1 Herbette M, Cren JB, Joffres L, Lucas C, Ricard E, Salliot C et al.. Usefulness of polymerase chain reaction for diagnosing Whipple's disease in rheumatology. PloS one 2018. link 2 Canessa PA, Pratticò L, Sivori M, Magistrelli P, Fedeli F, Cavazza A et al.. Acute fibrinous and organising pneumonia in Whipple's disease. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2008. link 3 Stoll T, Keusch G, Jost R, Burger H, Oelz O. IgA nephropathy and hypercalcemia in Whipple's disease. Nephron 1993. link

    Original source

    1. [1]
      Usefulness of polymerase chain reaction for diagnosing Whipple's disease in rheumatology.Herbette M, Cren JB, Joffres L, Lucas C, Ricard E, Salliot C et al. PloS one (2018)
    2. [2]
      Acute fibrinous and organising pneumonia in Whipple's disease.Canessa PA, Pratticò L, Sivori M, Magistrelli P, Fedeli F, Cavazza A et al. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace (2008)
    3. [3]
      IgA nephropathy and hypercalcemia in Whipple's disease.Stoll T, Keusch G, Jost R, Burger H, Oelz O Nephron (1993)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG